Accelerate to discover
Related topics
IncuCyte Live-Cell Analysis System - nearly 3,000 publications and counting!
Jan 21, 2020
IncuCyte has now reached over 2,000 cited publications! Search our publications filter to see what exciting research is...
Development of superparamagnetic nanoparticles as an efficient contrast agent for multimodal imaging
Jan 16, 2020
Gadolinium‐based contrast agents are used to provide diagnostic information in clinical magnetic resonance...
IncuCyte live-cell analysis system for live-cell visualization of neuronal activity
Jan 13, 2020
A major impediment to studying diseases affecting the human nervous system is the ability to monitor, analyze, and...
Latest updates to Bionano Access and Bionano Solve
Jan 8, 2020
Bionano Access v1.5 and Bionano Solve v3.5 are the latest updates to Bionano visualization software and analysis tools....
The qNano Gold: Obtain the most detailed Information for each individual nanoparticle
Jan 6, 2020
The qNano Gold measures particles using the Tunable Resistive Pulse Sensing (TRPS) principle. TRPS is the most powerful...
New analysis open modules expand capabilities of Guava Muse flow cytometer
Dec 30, 2019
Sophisticated cell analysis doesn’t have to be complicated or costly. With the Guava Muse cell analyzer, you can now...
High molecular weight DNA from bone marrow aspirates samples in 4 hrs
Dec 23, 2019
With Bionano Prep SP BMA DNA Isolation kit, transform the way you are isolating UHMW DNA from this complex sample type...
Cutting-edge analysis of Extracellular Microparticles using ImageStream Imaging Flow Cytometry
Dec 16, 2019
Interest in extracellular vesicle biology has exploded in the past decade, since these microstructures seem endowed...
May 18, 2016
With the increasing need for new therapies for cancer, autoimmune disorders and Alzheimer’s disease, monoclonal antibodies are proving very successful due to their high affinity and specificity for their target antigens. In cancer, for example, their first use was as antagonists of oncogenic receptor tyrosine kinases, but today monoclonal antibodies have emerged as vehicles for the targeted delivery of potent chemotherapeutic agents and as powerful tools to manipulate anticancer immune responses. Currently,
more than 30 antibody therapeutics are marketed worldwide. Some analysts predict that, given the rate of current revenue growth and potential new approvals, the global market could reach $58 billion by 2016. In addition, there are hundreds of monoclonal antibody-based biologic drugs in various phases of clinical trials worldwide.
Get more info
Brand profile
IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.
More info at:
www.intellicyt.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
